Breast cancer risk inBRCA1 andBRCA2 mutation carriers and polyglutamine repeat length in theAIB1 gene
Open Access
- 16 August 2005
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 117 (2) , 230-233
- https://doi.org/10.1002/ijc.21176
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer casesBritish Journal of Cancer, 2000
- Population-based study of risk of breast cancer in carriers of BRCA2 mutationThe Lancet, 1998
- Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer PatientsAmerican Journal of Human Genetics, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- BRCA1 mutations in young women with breast cancerThe Lancet, 1996
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994